Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 13 - Drugs for disorders of the urinary system
Patents for A61P 13 - Drugs for disorders of the urinary system (56,135)
10/2003
10/08/2003EP1349851A1 Compounds
10/08/2003EP1349840A2 Anilinopyrimidine derivatives as jnk pathway inhibitors and compositions and methods related thereto
10/08/2003EP1349839A1 Phenylethenyl or phenylethinyl derivatives as glutamate receptor antagonists
10/08/2003EP1349837A1 Antitumoral carbazoles
10/08/2003EP1349835A2 (+)-1-(3,4-dichlorophenyl)-3-azabicyclo 3.1.0]hexane, compositions and uses thereof
10/08/2003EP1349832A2 Substituted benzoindoles as spla2 inhibitors
10/08/2003EP1349562A2 Inhibiting gs-fdh to modulate no bioactivity
10/08/2003EP1349558A1 Composition comprising melissa leaf extract for anti-angiogenic and matrix metalloproteinase inhibitory activity
10/08/2003EP1349553A1 Dihydro-triterpenes in the treatment of viral infections, cardiovascular disease, inflammation, hypersensitivity or pain
10/08/2003EP1349546A2 Dissociated glucocorticoid receptor antagonists for the treatment of clucocorticoid associated side-effect
10/08/2003EP1214318B1 Imidazo[1,2-a]pyridine and pyrazolo[2,3-a]pyridine derivatives
10/08/2003EP1198464B1 8-PHENYL-6,9-DIHYDRO-[1,2,4]TRIAZOLO[3,4-i]PURIN-5-ONE DERIVATIVES
10/08/2003EP0946512B1 6-phenylpyridyl-2-amine derivatives useful as nos inhibitors
10/08/2003EP0927170B1 Piperazino derivatives as neurokinin antagonists
10/08/2003EP0812319B9 2-arylbenzazole compounds
10/08/2003CN1447817A Method for producing peptide salts. their use, and pharmaceutical prepns. containing these peptide salts
10/08/2003CN1447810A Bicyclo-pyrazoles active as kinase inhibitors,process for their prepn. and pharmaceutical compsns. comprising them
10/08/2003CN1447804A 1,3-bis-(substituted-phenyl)-2-propen-1-ones and their use to treat VCAM-1 mediated disorders
10/08/2003CN1447791A 10-aryl-11-hbenzo [b] fluorene derivatives and analogs for medicinal use
10/08/2003CN1447690A Inhibition of cystic fibrosis transmembrane conductance regulator chloride channel
10/08/2003CN1446790A Medicinal grade ferrum citricum iron-59 citrate and its preparation method
10/08/2003CN1446571A Pure Chinese herbal medicine formulation for treating nephritis
10/08/2003CN1446555A Medicine for treating insufficiency of the kidney-yang syndrome and its preparing method
10/08/2003CN1446547A New use in medicine for compound decoction for warming spleen of Chinese herbal medicine
10/08/2003CN1123573C 2-phenyl substituted imidazotrizainones as phosphodiesterase inhibitors
10/08/2003CN1123355C Medicine for treating pyelonephritis
10/08/2003CN1123344C Slowly-released agent of piperazine ferulate
10/07/2003US6630515 Urinary incontinence therapy
10/07/2003US6630500 Treating angiogenic disorders
10/07/2003US6630493 Heterocyclically substituted amides, their preparation and use
10/07/2003US6630492 Lymphocyte function antigen-1 antagonists
10/07/2003US6630162 Pharmaceutical formulation and its use
10/07/2003US6630157 Therapeutic and dietary compositions containing essential fatty acids and bioactive disulphides
10/07/2003CA2287552C Pyrazolopyrimidinone cgmp pde5 inhibitors for the treatment of sexual dysfunction
10/07/2003CA2263957C Diarylmethyl piperazine derivatives as delta opioid agonists
10/02/2003WO2003080673A1 Costimulatory molecule and its use
10/02/2003WO2003080630A2 Phosphate transport inhibitors
10/02/2003WO2003080626A1 Fused bicyclic pyridine derivative as tachykinin receptor antagonist
10/02/2003WO2003080619A1 Fused bicyclic pyrimidine derivatives
10/02/2003WO2003080611A1 Spiro derivatives and adhesion molecule inhibitors comprising the same as the active ingredient
10/02/2003WO2003080599A1 Stable hydrate of a muscarinic receptor antagonist
10/02/2003WO2003080592A1 2-pyrone compounds and use thereof
10/02/2003WO2003080579A1 Novel adamantane derivatives
10/02/2003WO2003080578A1 Heteroaromatic urea derivatives as vr-1 receptor modulators for treating pain
10/02/2003WO2003080568A2 Probucol derivatives
10/02/2003WO2003080556A1 Amine derivative with potassium channel regulatory function, its preparation and use
10/02/2003WO2003080144A1 Composition for hard tissue augmentation
10/02/2003WO2003080118A2 Combination of an aldosterone receptor antagonist and a fibric acid derivative
10/02/2003WO2003080103A1 Antagonists of megalin or cubilin for use in preventing organ damage induced by therapeutic agents
10/02/2003WO2003080070A2 Combination comprising an hmg-coa reductase inhibittor and an insulin secretor enhancer or an insulin sensitizer
10/02/2003WO2003080069A1 Combination of an aldosterone receptor antagonist and a bile acid sequestering agent
10/02/2003WO2003080068A1 Combination of an aldosterone receptor antagonist and nicotinic acid or a nicotinic acid derivative
10/02/2003WO2003080064A1 Kinase inhibitors
10/02/2003WO2003080058A1 Benzylimidazolyl substituted 2-quinoline and quinazoline derivatives for use as farnesyl transferase inhibitors
10/02/2003WO2003080054A1 Use of pyridyl amides as inhibitors of angiogenesis
10/02/2003WO2003080053A1 Combination treatments for chemokine-mediated diseases
10/02/2003WO2003080047A1 Phosphate prodrugs of fluorooxindoles
10/02/2003WO2003080038A1 Preventive or therapeutic agent for kidney disease
10/02/2003WO2003079993A2 hGH (HUMAN GROWTH HORMONE) FORMULATIONS FOR PULMONARY ADMINISTRATION
10/02/2003WO2003079991A2 Method for administration of growth hormone via pulmonary delivery
10/02/2003WO2003079969A2 Compositions and methods for treating and preventing necrosis
10/02/2003WO2003079750A2 ANTAGONISTIC ANTI-hFAS LIGAND HUMAN ANTIBODIES AND FRAGMENTS THEREOF
10/02/2003WO2003053358A3 Fused heterocyclic compounds and analogs thereof: modulators of nuclear hormone receptor function
10/02/2003WO2003042173A8 Nk1 antagonists
10/02/2003WO2002092759A3 Molecules for disease detection and treatment
10/02/2003WO2002074323A3 Using neural thread proteins to treat tumors and other hyperproliferative disorders
10/02/2003WO2002026781A3 Ige receptor antagonists
10/02/2003WO2002022573A3 Methods and compositions relating to hydrogen peroxide and superoxide production by antibodies
10/02/2003WO2002000656A3 Pirazino '1$m(1)2$m(1) :1, 6! pyrido '3,4-b! indole derivatives
10/02/2003US20030187260 Thienopyrimidines
10/02/2003US20030187058 Synergistic mixture of lipoic acid and another fatty acid; antidiabetic agents
10/02/2003US20030187040 2-Ureido-thiazole derivatives, process for their preparation, and their use as antitumor agents
10/02/2003US20030187009 Analgesics, diarrhea, anticonvulsants, antitussive agents or drug abuse therapy
10/02/2003US20030187007 Inhibitors of protein kinase for the treatment of disease
10/02/2003US20030186994 Anticholesterol agents; cardiovascular disorders
10/02/2003US20030186989 Antihistamines; respiratory system disorders
10/02/2003US20030186987 Bicyclic compounds capable of inhibiting tyrosine kinases of the epidermal growth factor receptor family
10/02/2003US20030186981 Antiinflammatory agents; osteoporosis; rheumatic diseases; autoimmune diseases
10/02/2003US20030186979 Hydroxyformamidine derivatives and medicines containing the same
10/02/2003US20030186977 Use of pdgf receptor tyrosine kinase inhibitors for the treatment of diabetic nephropathy
10/02/2003US20030186974 Pyrrolyl- and imidazolyl-acid amide derivatives useful as inhibitors of PDE4 isozymes
10/02/2003US20030186970 Androgen receptor modulator compounds and methods
10/02/2003US20030186964 Piperdines for use as orexin receptor antagonists
10/02/2003US20030186957 Methods of treatment and formulations of cephalosporin
10/02/2003US20030186945 Method of preparing and use of prodrugs of betulinic acid derivatives
10/02/2003US20030186922 Therapeutic use of cis-element decoys in vivo
10/02/2003US20030186907 Endometrial function
10/02/2003US20030186905 Cis-acting regulatory nucleic acid sequences in the parathyroid hormone3' -untranslated region
10/02/2003US20030186902 Use of a pituitary tumor transforming gene peptide which has the ability to regulate endogenous PTTG1 expression and/or function in a dominant negative manner
10/02/2003US20030186896 Crystalline form of perindopril tert-butylamine salt
10/02/2003US20030186891 Polypeptide comprising fragments of matrix extracellular phosphoglycoproteins used to control calcitriol concentrations in cells, for prophylaxis of bone disorders
10/02/2003US20030186889 Diagnostic and medicament for analysing the cell surface proteome of tumour and inflammatory cells and for treating tumorous and inflammatory diseases, preferably using a specific chemokine receptor analysis and the chemokine receptor-ligand interaction
10/02/2003US20030186845 Compositions for preventing urinary calculus
10/02/2003US20030186424 Reagents and methods for identifying and modulating expression of genes regulated by CDK inhibitors
10/02/2003US20030186381 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
10/02/2003US20030186308 Prostacyclin-stimulating factor-2
10/02/2003US20030185823 Arming of activated T cells with BiAbs increases the effective precursor frequency of CTL in the cancer patient.
10/02/2003US20030185815 Novel antibodies that bind to antigenic polypeptides, nucleic acids encoding the antigens, and methods of use
10/02/2003CA2480302A1 Compositions and methods for treating and preventing necrosis
10/02/2003CA2480039A1 Spiro derivatives and adhesion molecule inhibitors comprising the same as active ingredient
1 ... 338 339 340 341 342 343 344 345 346 347 348 349 350 351 352 353 354 355 356 357 358 ... 562